|
EHBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6627810239811E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.7715611723761E-16 |
| Normal-vs-Stage2 |
1.882620E-03 |
| Normal-vs-Stage3 |
5.999700E-04 |
| Normal-vs-Stage4 |
7.836400E-01 |
| Stage1-vs-Stage2 |
9.582800E-01 |
| Stage1-vs-Stage3 |
1.093690E-02 |
| Stage1-vs-Stage4 |
4.47100001466083E-09 |
| Stage2-vs-Stage3 |
1.787410E-01 |
| Stage2-vs-Stage4 |
4.260300E-03 |
| Stage3-vs-Stage4 |
8.159100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63169477929159E-12 |
| Normal-vs-AfricanAmerican |
2.381000E-01 |
| Normal-vs-Asian |
1.854640E-01 |
| Caucasian-vs-AfricanAmerican |
2.143900E-02 |
| Caucasian-vs-Asian |
2.729200E-01 |
| AfricanAmerican-vs-Asian |
7.178200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.75710000280571E-08 |
| Normal-vs-Female |
1.59270374666676E-11 |
| Male-vs-Female |
7.415100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.150400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.33760000245553E-09 |
| Normal-vs-Age(61-80Yrs) |
5.22009990788774E-10 |
| Normal-vs-Age(81-100Yrs) |
5.810200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.083300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.661200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.217580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.888800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.885800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.652000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.379200E-03 |
| Normal-vs-Grade 2 |
1.0325074129014E-14 |
| Normal-vs-Grade 3 |
1.3131999998528E-07 |
| Normal-vs-Grade 4 |
3.940400E-01 |
| Grade 1-vs-Grade 2 |
2.108400E-01 |
| Grade 1-vs-Grade 3 |
3.920200E-02 |
| Grade 1-vs-Grade 4 |
1.399990E-03 |
| Grade 2-vs-Grade 3 |
3.156100E-02 |
| Grade 2-vs-Grade 4 |
7.90449927734471E-11 |
| Grade 3-vs-Grade 4 |
2.64019999995924E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
2.858200E-01 |
| ccA subtype-vs-ccB subtype |
1.62447832963153E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.32219995957672E-09 |
| Normal-vs-N1 |
3.516200E-01 |
| N0-vs-N1 |
1.943810E-02 |
|
|
